Litcius/Paper detail

Sacituzumab Govitecan: A Review in Unresectable or Metastatic HR+/HER2− Breast Cancer

Connie Kang

2024Targeted Oncology12 citationsDOIOpen Access PDF

Topics & Concepts

MedicineMetastatic breast cancerInternal medicineBreast cancerOncologyVinorelbineTolerabilityEribulinFebrile neutropeniaNeutropeniaCancerAdverse effectChemotherapyCisplatinAdvanced Breast Cancer TherapiesHER2/EGFR in Cancer ResearchLung Cancer Research Studies
Sacituzumab Govitecan: A Review in Unresectable or Metastatic HR+/HER2− Breast Cancer | Litcius